Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-48900 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- UGT2A3 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 400 µL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression.
Wu J, Zhang T, Chen Y, Ha S
Bioscience reports 2020 May 29;40(5)
Bioscience reports 2020 May 29;40(5)
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of UGT2A3 in NCI-H460 cell line lysates (35 µg/lane). Lysates were probed with a UGT2A3 Antibody (Center) (Product # PA5-48900).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 3 SLITRK4 is the potential target of miR-139-5p in HCC ( A ) The potential downstream genes were predicted by the OncomiR database. ( B and C ) Western blots were used to check related protein expressions after oemiR-139-5p or adding miR-139-5p inhibitor into HCC cells. ( D and E ) SLITRK4 expression in liver tumors and normal tissues and the survival rate were analyzed by GEPIA database ( http://gepia.cancer-pku.cn/index.html ).